The ACIST CVi Contrast Delivery System provides one injection system for all cardiac and vascular angiography procedures. The variable-rate ACIST CVi system aims to provide ease of operation for clinicians, while obtaining quality images with less contrast used and delivered to the patient.
The patented AngioTouch hand controller allows variable-rate injection of contrast flow, from a puff to full injection (variable rate injection from 0.8 – 40 mL/sec). The ACIST CVi is a fourth-generation product, and ACIST contrast delivery systems have been used in over 4 million procedures in more than 40 countries.


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now